日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model.

在 rTg4510 tau 病模型中,pS396/pS404 (PHF1) tau 疫苗优于 pS199/pS202 (AT8)

Hulse Jonathan P, Maphis Nicole M, Peabody Julianne, Bondu Virginie, Chackerian Bryce, Bhaskar Kiran

A model for predicting bacteremia species based on host immune response.

基于宿主免疫反应预测菌血症菌种的模型

Simons Peter, Bondu Virginie, Shevy Laura, Young Stephen, Wandinger-Ness Angela, Bologa Cristian G, Buranda Tione

Pathological tau activates inflammatory nuclear factor-kappa B (NF-κB) and pT181-Qβ vaccine attenuates NF-κB in PS19 tauopathy mice

病理性tau蛋白激活炎症性核因子-κB (NF-κB),而pT181-Qβ疫苗可减弱PS19 tau蛋白病小鼠中的NF-κB活性。

Tangavelou, Karthikeyan; Jiang, Shanya; Dadras, Somayeh; Hulse, Jonathan P; Sanchez, Kathryn; Bondu, Virginie; Villaseñor, Zachary; Mandell, Michael; Peabody, Julianne; Chackerian, Bryce; Bhaskar, Kiran

The deubiquitinase OTULIN regulates tau expression and RNA metabolism in neurons

去泛素酶 OTULIN 调节神经元中 tau 表达和 RNA 代谢

Tangavelou, Karthikeyan; Bondu, Virginie; Li, Mingqi; Li, Wei; Liao, Francesca-Fang; Bhaskar, Kiran

Infectious titres of human papillomaviruses (HPVs) in patient lesions, methodological considerations in evaluating HPV infectivity and implications for the efficacy of high-level disinfectants

患者病灶中人乳头瘤病毒 (HPV) 的感染滴度、评估 HPV 感染性的方法学考量及其对高效消毒剂功效的影响

Ozbun, Michelle A; Bondu, Virginie; Patterson, Nicole A; Sterk, Rosa T; Waxman, Alan G; Bennett, Erica C; McKee, Rohini; Sharma, Ankur; Yarwood, Jeremy; Rogers, Marc; Eichenbaum, Gary

Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and Oligomers

共轭聚合物和低聚物对SARS-CoV-2的高效灭活作用

Schanze, Kirk S; Whitten, David G; Kell, Alison M; Chi, Eva Y; Ista, Linnea K; Monge, Florencia A; Jagadesan, Pradeepkumar; Bondu, Virginie; Donabedian, Patrick L